Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kerstin Killer"'
Autor:
Alexandra Langlois, Marie-Hélène Lavergne, Hélène Leroux, Kerstin Killer, Pauline Azzano, Louis Paradis, Kathryn Samaan, Jonathan Lacombe-Barrios, Benoît Mâsse, Anne Des Roches, Philippe Bégin
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-16 (2020)
Abstract Background Previous proof-of-concept studies have shown that a short course of omalizumab can safely accelerate the oral immunotherapy schedule for multiple allergens simultaneously. Considering the high cost of medication, the dose-related
Externí odkaz:
https://doaj.org/article/3437e5ba95094accb2eee8ddde179ce1
Autor:
Alexandra Langlois, Marie-Hélène Lavergne, Hélène Leroux, Kerstin Killer, Pauline Azzano, Louis Paradis, Kathryn Samaan, Jonathan Lacombe-Barrios, Thomas Eiwegger, Julia Upton, Gordon Sussman, Thomas Poder, Benoît Mâsse, Anne Des Roches, Philippe Bégin
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-2 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/65f838091f7041059807138ea00b9c8a
Publikováno v:
Radiation research. 196(3)
Decreased neurogenesis after brain exposure to ionizing radiation is linked to neurocognitive impairments. Using transgenic mouse models, we previously showed that abrogation of radiation-induced senescence, or apoptosis, can partially rescue neuroge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a1451b284f214f07c5b8820f21dc1bc
https://pubmed.ncbi.nlm.nih.gov/34107047
https://pubmed.ncbi.nlm.nih.gov/34107047
Autor:
Louis Paradis, Benoît Mâsse, Alexandra Langlois, Thomas G. Poder, Philippe Bégin, Jonathan Lacombe-Barrios, Thomas Eiwegger, Anne Des Roches, Gordon Sussman, Kerstin Killer, Hélène Leroux, Kathryn Samaan, Julia Upton, Marie-Hélène Lavergne, Pauline Azzano
Publikováno v:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-16 (2020)
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-16 (2020)
Background Previous proof-of-concept studies have shown that a short course of omalizumab can safely accelerate the oral immunotherapy schedule for multiple allergens simultaneously. Considering the high cost of medication, the dose-related efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a88294c03067d775000bd230282b04f2
https://doi.org/10.1186/s13223-020-00419-z
https://doi.org/10.1186/s13223-020-00419-z
Publikováno v:
Allergy. 71(12)
Background The prevalence of peanut allergy in younger siblings of children with peanut allergy has been reported between 7% and 8.5%, but the anaphylactic risk at the time of introduction is currently unknown, which limits our ability to best counse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::648ba450da3f41eb778c76aa83c0abdd
https://pubmed.ncbi.nlm.nih.gov/27291651
https://pubmed.ncbi.nlm.nih.gov/27291651
Publikováno v:
BMC Microbiology
Background Smokers are more prone to oral infections than are non-smokers. Cigarette smoke reaches the host cells but also microorganisms present in the oral cavity. The contact between cigarette smoke and oral bacteria promotes such oral diseases as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e1c38e11bce423f9b34524ad56d505c
http://europepmc.org/articles/PMC3995653
http://europepmc.org/articles/PMC3995653